Product image of Minirin/Ddavp (Desmopressin) supplied by GNH India

Minirin/Ddavp

Active Ingredient:
Desmopressin
Origin:
EU

Minirin/Ddavp (Desmopressin)

Desmopressin, the active ingredient in Minirin/Ddavp, is a vasopressin (antidiuretic hormone) analog presented as an oral formulation for prescription use. It is employed to reduce excessive urine production and to aid certain bleeding disorders.
GNH India supplies Minirin/Ddavp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ferring S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin acts on the antidiuretic pathway to manage conditions characterized by water balance disturbances or clotting factor deficiencies.

  • Central diabetes insipidus: reduces excessive urine output by concentrating urine.
  • Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adults.
  • Mild hemophilia A: raises plasma factor VIII levels to improve clotting.
  • von Willebrand disease: enhances von Willebrand factor release to control bleeding.

How It Works

  • Desmopressin is a synthetic analog of vasopressin that selectively binds to V2 receptors on the renal collecting duct cells. Activation of these receptors stimulates adenylate cyclase, increasing cyclic AMP, which promotes insertion of aquaporin‑2 water channels into the apical membrane, thereby enhancing water reabsorption and concentrating urine.

Side Effects

Desmopressin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Hyponatremia: low blood sodium levels, often presenting with headache or nausea.
  • Headache: mild to moderate intensity.
  • Nausea or abdominal cramps: gastrointestinal discomfort.
  • Facial flushing: transient redness of the skin.
  • Nasal congestion (if nasal formulation is used).

Serious or Rare Side Effects

  • Water intoxication: severe hyponatremia leading to seizures or coma.
  • Severe hyponatremia: can cause cerebral edema and neurological deficits.
  • Allergic reactions: rash, itching, or anaphylaxis.
  • Thrombotic events: rare clot formation in predisposed individuals.

Precautions & Warnings

Before initiating therapy, consider patient‑specific factors and monitoring requirements.

  • Dose adjustment in renal impairment: reduce dose as needed and monitor fluid balance.
  • Monitor serum sodium: check electrolytes regularly to avoid hyponatremia.
  • Avoid concomitant use with thiazide diuretics: increased risk of low sodium.
  • Use caution in heart failure: risk of fluid overload.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Desmopressin can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Thiazide diuretics: may potentiate hyponatremia.
  • NSAIDs: can enhance antidiuretic effect and fluid retention.
  • Carbamazepine: reduces desmopressin effectiveness.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: monitor blood pressure and electrolytes.
  • SSRIs: increased risk of hyponatremia.
  • Alcohol: may exacerbate fluid imbalance.

Frequently Asked Questions

Minirin/Ddavp (desmopressin) is prescribed for central diabetes insipidus, nocturnal enuresis, mild hemophilia A, and von Willebrand disease. In each case the drug helps to either reduce excessive urine output or increase clotting factor levels, addressing the underlying physiological deficit.

Desmopressin mimics the natural hormone vasopressin and selectively activates V2 receptors in the kidney’s collecting ducts. This triggers a cascade that inserts aquaporin‑2 channels into the duct lining, allowing more water to be reabsorbed, which concentrates urine and raises plasma levels of clotting factors when needed.

The dosage of Minirin/Ddavp is individualized by the prescribing clinician based on the patient’s age, weight, renal function and the specific indication. Only a qualified health professional should determine the appropriate dose and schedule.

Safety data for desmopressin in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a healthcare provider.

To request Minirin/Ddavp, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Desmopressin is a synthetic vasopressin analog with high selectivity for V2 receptors, offering a more targeted antidiuretic effect and fewer vasoconstrictive actions than older agents like vasopressin itself. This selectivity generally results in a better safety profile for long‑term use in the approved indications.

Store Minirin/Ddavp at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Minirin/Ddavp is taken orally as directed by a healthcare professional. The tablet or oral solution should be swallowed with water, usually at the same time each day, and patients should follow any specific instructions regarding food or fluid intake provided by their prescriber.

The most serious risks include severe hyponatremia leading to seizures, cerebral edema, or coma, and rare cases of water intoxication. Patients should be monitored for signs of low sodium, especially when fluid intake is high or when interacting drugs increase the antidiuretic effect.

Minirin/Ddavp is contraindicated in individuals with known hypersensitivity to desmopressin, uncontrolled hyponatremia, or severe renal impairment where fluid balance cannot be safely managed. It should also be used with caution in patients with heart failure or uncontrolled hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desmopressin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT